does retatrutide cause weight loss Retatrutide: A Multi-Receptor Approach to Management Retatrutide UK 2026: Phase 3

To reconcile the findings that both GIPR antagonists and GIPRAs reduce body weight, it is possible that physiological GIPR activity plays a permissive role in adipose tissue synthesis, while pharmacologically enhanced GIPR activity may reduce body weight through a different mechanism in the brain

Great, a new GLP-1 side effect to worry about

Conclusion GLP-1 medications have catalyzed one of the most profound shifts in medical weight-loss care in decades

The weight loss mechanism differs as well: GLP-1 agonists work through delayed gastric emptying and central appetite suppression, while berberine's weight effects, when present, likely relate to improved insulin sensitivity and metabolic efficiency